SCHEMBL30877256

SCHEMBL30877256

CCCN(CCC)CCc1c[nH]c2c(F)cc(OC)cc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 5/20 0.50
HTR1D P28221 6/20 0.47
HTR1B P28222 3/20 0.47
HTR2A P28223 5/20 0.46
MTNR1A P48039 6/20 0.44
MTNR1B P49286 6/20 0.44
HTR2C P28335 2/20 0.44
HTR1E P28566 2/20 0.44
HTR7 P34969 2/20 0.44
HTR2B P41595 2/20 0.44
HTR5A P47898 2/20 0.44
HTR6 P50406 2/20 0.44
ADRA2A P08913 1/20 0.44
ADRA2B P18089 1/20 0.44
ADRA2C P18825 1/20 0.44
SLC6A2 P23975 1/20 0.44
HRH2 P25021 1/20 0.44
SLC6A4 P31645 1/20 0.44
HRH1 P35367 1/20 0.44
DRD3 P35462 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29206468 1.00 HTR1A (0.50) HTR1AHTR1DHTR1BHTR2AMTNR1A
SCHEMBL29206473 0.95 HTR1A (0.54) HTR1AHTR1DHTR1BHTR2AMTNR1A
SCHEMBL25748619 0.91 HTR1A (0.61) HTR1AHTR1DHTR1BHTR2AMTNR1A
SCHEMBL29206500 0.90 MTNR1A (0.46) HTR1AHTR1DHTR1BHTR2AMTNR1A
SCHEMBL30877200 0.90 MTNR1A (0.46) HTR1AHTR1DHTR1BHTR2AMTNR1A
SCHEMBL24694054 0.86 HTR2A (0.52) HTR1AHTR1DHTR1BHTR2AMTNR1A
SCHEMBL25748004 0.86 MTNR1A (0.59) HTR1AHTR1DHTR1BHTR2AMTNR1A
SCHEMBL31158584 0.85 HTR1A (0.41) HTR1AHTR1DHTR1BHTR2AMTNR1A
SCHEMBL29206471 0.85 HTR1A (0.41) HTR1AHTR1DHTR1BHTR2AMTNR1A
SCHEMBL30877243 0.85 HTR1A (0.59) HTR1AHTR1DHTR1BHTR2AMTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117957211-A Fluorinated tryptamine compounds, analogs thereof, and methods of use thereof 圣约瑟夫大学 2024-04-30 CN claimed
US-20240286998-A1 FLUORINATED TRYPTAMINE COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME SAINT JOSEPH'S UNIVERSITY 2024-08-29 US disclosed
CN-117957211-A Fluorinated tryptamine compounds, analogs thereof, and methods of use thereof 圣约瑟夫大学 2024-04-30 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240286998-A1 FLUORINATED TRYPTAMINE COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME TPH2, TPH1, HNMT HTR1A 9/4885HTR1D 27/4885HTR1B 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.